GO
Loading...

Drugs

More

  • E-cigarettes: a burning question for U.S. regulators Wednesday, 11 Dec 2013 | 1:33 PM ET

    NEW YORK, Dec 11- At the Henley Vaporium, one of a growing number of e-cigarette lounges sprouting up in New York and other U.S. cities, patrons can indulge in their choice of more than 90 flavors of nicotine-infused vapor, ranging from bacon to bubble gum.

  • Living with a drug addict: The financial realities Wednesday, 11 Dec 2013 | 10:05 AM ET

    Having an addict in the family presents a deeply troubling dilemma. How do you help those you love, while protecting your own financial future?

  • Pharma fights the Superbug     Tuesday, 10 Dec 2013 | 4:53 PM ET

    CNBC's Bertha Coombs reports on the race to treat drug-resistant infections.

  • Seattle throws a pot party     Friday, 6 Dec 2013 | 10:20 AM ET

    Ben Livingston, director of the Center for Legal Cannabis, discusses the legalization anniversary event.

  • KISMAYU, Somalia, Dec 4- Al Qaeda- linked militants, drug smugglers and shadowy criminal networks stand in the way of the Somali federal government's hopes of hiring a foreign firm to manage the lucrative but run-down southern port of Kismayu.

  • Pot entrepreneur: High growth expected for biz Friday, 22 Nov 2013 | 12:53 PM ET

    A Colorado medical marijuana dispensary became the first business in the U.S. licensed to sell recreational marijuana.

  • *Diet drugs and plans a hard sell, despite rising obesity. KALUNDBORG, Denmark, Nov 14- Steam rises from pipes at a giant industrial complex on the edge of the Baltic Sea whose success is a testament to the world's diabetes and obesity epidemic.

  • GlaxoSmithKline heart drug misses goal in major study Tuesday, 12 Nov 2013 | 6:17 AM ET

    An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major clinical study.

  • Shire to pay $4.2 billion for ViroPharma Monday, 11 Nov 2013 | 4:21 AM ET

    London-listed Shire has agreed to buy U.S. company ViroPharma for about $4.2 billion in cash.

  • FDA weighs generic drugmakers' accountability Friday, 8 Nov 2013 | 5:18 PM ET

    The FDA proposed a new rule that would open up generic drugmakers to liability and apply some of the same regulations used for brand manufacturers.

  • A marijuana muni bond?     Wednesday, 6 Nov 2013 | 1:47 PM ET

    CNBC's Tyler Mathisen, Jon Fortt and Michelle Caruso-Cabrera debate the money to be made from the legalization of marijuana.

  • Oct 22- Pfizer Inc said it has decided to develop the abuse-resistant painkiller made by its partner Pain Therapeutics Inc, six months after the pharmaceutical giant's comments raised fears it would drop the drug. Pain Therapeutics shares jumped as much as 30 percent in early trading on the Nasdaq.

  • Move over, Viagra. There's a new sex drug in town Thursday, 3 Oct 2013 | 1:52 PM ET

    You've heard of ED. Now there's a drug for PE, made by a 4-year-old start-up. It's designed for men to make their mates happier.

  • Will.i.am: prison problem is 'embarrassing'     Monday, 16 Sep 2013 | 7:00 PM ET

    Will.i.am talks to CNBC about the "failure" of the Drug Abuse Resistance Education program and how thousands of Americans are now in prison because of lack of opportunities in their neighborhood.

  • Studies back fast OK for Roche cancer drug: FDA Tuesday, 10 Sep 2013 | 1:58 PM ET

    The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.

  • Biogen makes another big bet on Isis technology Monday, 9 Sep 2013 | 10:53 AM ET

    Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop neurological medicines.

  • Legal pot creates jobs, big biz interested: Expert Friday, 30 Aug 2013 | 12:12 PM ET

    The cannabis legalization trend is creating jobs in states where laws have been relaxed, and big business is "looking into the industry in a big way," an expert says.

  • Pot stock scams     Tuesday, 20 Aug 2013 | 3:40 PM ET

    A warning about stock scams involving marijuana related companies has been issued; CNBC's Mary Thompson has the story.

  • Scammers target pot stocks     Tuesday, 20 Aug 2013 | 1:58 PM ET

    FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.

  • Marijuana stock shills are blowing smoke, US warns Tuesday, 20 Aug 2013 | 1:38 PM ET

    FINRA warned Tuesday that scammers have been targeting investors attempting to tap into the growing U.S. marijuana industry.

Most Popular Video

Thursday, 17 Apr 2014 | 12:58 PM ET

The FMHR traders reveal their final trades.

Friday, 18 Apr 2014 | 11:00 AM ET

Are economic growth expectations too high? CNBC's Jeff Cox explains.

Friday, 18 Apr 2014 | 12:00 PM ET

CNBC's Stephanie Landsman discusses how the luxury rental boom isn't confined to New York City and its boroughs, but that developers are seeing new opportunities in New Jersey.